Share of people with HIV who receive antiretroviral therapy in Fiji
Fiji: Share of people with HIV who receive antiretroviral therapy was 24.0% in 2024. ◆ Volatile
Share of people with HIV who receive antiretroviral therapy in Fiji, 2000–2024
Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of people living with HIV.
Analysis
Fiji recorded 24.0% for share of people with hiv who receive antiretroviral therapy in 2024.
That represents a change of up 60.0% on the previous year and down 41.5% over ten years.
Over the whole period, share of people with hiv who receive antiretroviral therapy in Fiji peaked at 84.0% in 2005 and was at its lowest, 0.0%, in 2000.
Fiji ranks 140th of 143 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Share of people with HIV who receive antiretroviral therapy in Fiji, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 68.0% | — |
| 2005 | 84.0% | +23.5% |
| 2006 | 81.0% | -3.6% |
| 2007 | 73.0% | -9.9% |
| 2008 | 72.0% | -1.4% |
| 2009 | 64.0% | -11.1% |
| 2010 | 58.0% | -9.4% |
| 2011 | 51.0% | -12.1% |
| 2012 | 62.0% | +21.6% |
| 2013 | 47.0% | -24.2% |
| 2014 | 41.0% | -12.8% |
| 2015 | 32.0% | -22.0% |
| 2016 | 26.0% | -18.8% |
| 2017 | 25.0% | -3.8% |
| 2018 | 25.0% | +0.0% |
| 2019 | 24.0% | -4.0% |
| 2020 | 21.0% | -12.5% |
| 2021 | 22.0% | +4.8% |
| 2022 | 15.0% | -31.8% |
| 2023 | 15.0% | +0.0% |
| 2024 | 24.0% | +60.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 44.2% | 0.0% | 84.0% | 10 |
| 2010s | 39.1% | 24.0% | 62.0% | 10 |
| 2020s | 19.4% | 15.0% | 24.0% | 5 |
Countries ranked near Fiji
More health data for Fiji
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4425 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,339 deaths per 1,000 people (2090)
- Number of infants who die before age 1 77 deaths (2100)
- Population ages 75-79, female, annual growth rate 1.36 % change on previous year (2025)
- Population ages 75-79, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, female, per capita 0.0067 units per person (2025)
- Population ages 75-79, male, annual growth rate 0.968 % change on previous year (2025)
- Population ages 75-79, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, male, per capita 0.0044 units per person (2025)
Frequently asked questions
- What is share of people with hiv who receive antiretroviral therapy in Fiji?
- Share of people with hiv who receive antiretroviral therapy in Fiji was 24.0% in 2024, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
- What is the highest share of people with hiv who receive antiretroviral therapy recorded in Fiji?
- The highest recorded value was 84.0% in 2005.
- What is the lowest share of people with hiv who receive antiretroviral therapy recorded in Fiji?
- The lowest recorded value was 0.0% in 2000.
- How does Fiji rank for share of people with hiv who receive antiretroviral therapy?
- Fiji ranks 140th out of 143 countries with data for 2024.
- Is share of people with hiv who receive antiretroviral therapy rising or falling in Fiji?
- Over the last ten years it is down 41.5%. The long-run trend across the full record is volatile.
- Where does this Fiji data come from?
- The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of people with HIV who receive antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.